Brief: FDA Approves Update To USPI For Agios Pharmaceuticals's Pyrukynd For Hemolytic Anemia

Agios Pharmaceuticals

06/01/2025 12:02

Jan 6 (Reuters) - Agios Pharmaceuticals Inc  AGIO.O :
    * AGIOS PHARMACEUTICALS - FDA APPROVES UPDATE TO USPI FOR
PYRUKYND
FOR HEMOLYTIC ANEMIA
    * AGIOS PHARMACEUTICALS - USPI SECTIONS UPDATED TO INCLUDE
LIVER
INJURY INFORMATION
    * AGIOS PHARMACEUTICALS - TO DISCONTINUE PYRUKYND IF HEPATIC
INJURY DUE TO PYRUKYND IS SUSPECTED

Source text:  ID:n0001193125-25-001809 
Further company coverage:  AGIO.O 

 ((Reuters.Brief@thomsonreuters.com))